---
layout: post
title: "Vintage Pharmaceuticals; Withdrawal of Approval of Abbreviated New Drug Application for Pemoline Tablets, 18.75 Milligrams, 37.5 Milligrams, and 75 Milligrams"
date: 2026-02-05 18:55:46 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-11991
original_published: 2023-06-06 00:00:00 +0000
significance: 8.00
---

# Vintage Pharmaceuticals; Withdrawal of Approval of Abbreviated New Drug Application for Pemoline Tablets, 18.75 Milligrams, 37.5 Milligrams, and 75 Milligrams

**Published:** February 05, 2026 18:55 UTC
**Source:** Federal Register
**Original Published:** June 06, 2023 00:00 UTC
**Document Number:** 2023-11991

## Summary

The Food and Drug Administration (FDA or Agency) is withdrawing approval of abbreviated new drug application (ANDA) 075328 for pemoline tablets, 18.75 milligrams (mg), 37.5 mg, and 75 mg, held by Vintage Pharmaceuticals, 120 Vintage Dr., Huntsville, AL 35811 (Vintage). Vintage requested that approval of this application be withdrawn and has waived its opportunity for a hearing.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/06/06/2023-11991/vintage-pharmaceuticals-withdrawal-of-approval-of-abbreviated-new-drug-application-for-pemoline)
- API: https://www.federalregister.gov/api/v1/documents/2023-11991

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
